Not applicableStudy completedNCT04467268What this trial is testingSleep Extension for Metabolic HealthWho this might be right forShort Sleep Loughborough University 18
Testing effectiveness (Phase 2)Study completedNCT01193218What this trial is testingEmpagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 547
Not applicableWithdrawnNCT06692153What this trial is testingEmbecta AID System in Adults With Type 2 DiabetesWho this might be right forType 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DM+4 more Embecta Corp.
Large-scale testing (Phase 3)Study completedNCT01392677What this trial is testingEvaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaWho this might be right forType 2 Diabetes MellitusHigh HbA1c LevelInadequate Glycaemic Control AstraZeneca 311
Large-scale testing (Phase 3)Study completedNCT01214239What this trial is testingEfficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic ControlWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 300
Large-scale testing (Phase 3)Study completedNCT01210001What this trial is testingEfficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 499
Large-scale testing (Phase 3)Study completedNCT00683657What this trial is testingSafety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR AloneWho this might be right forType 2 Diabetes AstraZeneca 93
Large-scale testing (Phase 3)Study completedNCT02577016What this trial is testingDouble-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 141
Testing effectiveness (Phase 2)Study completedNCT01096667What this trial is testingStudy of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)Who this might be right forDiabetes Mellitus, Type 2Hypertension Merck Sharp & Dohme LLC 194
Large-scale testing (Phase 3)Ended earlyNCT03608358What this trial is testingSafety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinWho this might be right forType 2 Diabetes Mellitus AstraZeneca 41
Large-scale testing (Phase 3)Study completedNCT00432276What this trial is testingEfficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus Takeda 803
Large-scale testing (Phase 3)Study completedNCT00313313What this trial is testingSaxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasWho this might be right forDiabetes AstraZeneca 768
Large-scale testing (Phase 3)Study completedNCT02229396What this trial is testingPhase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching PlaceboWho this might be right forDiabetes Mellitus AstraZeneca 695
Large-scale testing (Phase 3)Study completedNCT03066830What this trial is testingEfficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With MetforminWho this might be right forType 2 Diabetes Mellitus Lexicon Pharmaceuticals 507
Large-scale testing (Phase 3)Study completedNCT00147758What this trial is testingWelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Daiichi Sankyo 400
Post-approval studies (Phase 4)Study completedNCT02471404What this trial is testingEfficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaWho this might be right forType 2 Diabetes MellitusInadequate Glycaemic Control AstraZeneca 939
Post-approval studies (Phase 4)Study completedNCT00941148What this trial is testingBeta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With MetforminWho this might be right forType 2 Diabetic PatientsInsufficient Metabolic ControlOAD Treatment ikfe-CRO GmbH 30
Post-approval studies (Phase 4)Study completedNCT01438814What this trial is testingLinagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 689
Large-scale testing (Phase 3)Study completedNCT00622284What this trial is testingEfficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 1,560
Large-scale testing (Phase 3)Ended earlyNCT01678820What this trial is testingThe Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 299